Key facts
| Price (PPV) | 84.20 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | carvédilol |
| Class | Beta blocking agents |
| ATC code | C07AG02 |
| Manufacturer | PHI |
| Presentation | Boîte de 28 |
| Nature | Médicament |
| Hospital price | 52.60 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement de l'insuffisance cardiaque chronique stable, légère, modérée et sévère (fraction d'éjection ≤ 35%), en association avec le traitement conventionnel comportant inhibiteur de l'enzyme de conversion, diurétique et, le plus souvent, digitalique. - Dans un programme d'études cliniques, chez des patients en insuffisance cardiaque légère à modérée, le carvédilol a permis de réduire la mortalité à 6 mois de 50%, IC 95% [33% - 75%]. - Dans l'étude COPERNICUS menée chez des patients en insuffisance cardiaque sévère non décompensée, le carvédilol a permis de réduire la mortalité à 1 an de 35%, IC 95% [19% - 48%].
Find an open pharmacy
On-call pharmacies near you
Same-strength alternatives — cheapest first
Cardinor 25 mg (COOPER PHARMA) contains the same active substance as Cardix 25 mg (Carvédilol) at the same strength, but in a different pack: Boîte de 30 at 88.10 MAD, i.e. 2.94 MAD per unit against 3.01 MAD for Cardix 25 mg. The public sale price is set by the Ministry of Health: it is identical in every pharmacy.
| Product | Manufacturer | Pack | PPV | Unit price |
|---|---|---|---|---|
| Cardinor 25 mg | COOPER PHARMA | Boîte de 30 | 88.10 MAD | 2.94 / unit |
| Celeno 25 mg | PHARMIS | Boite de 30 | 88.10 MAD | 2.94 / unit |
| Coronat 25 mg | ATLAS PHARM | Boîte de 30 | 88.10 MAD | 2.94 / unit |
| Xedilol 25 mg | SOTHEMA | Boîte de 30 | 88.10 MAD | 2.94 / unit |
| Dilatrend 25 mg | BOTTU S.A. | Boîte de 30 | 125 MAD | 4.17 / unit |
| Cardinor 25 mg | COOPER PHARMA | Boîte de 60 | 172.20 MAD | 2.87 / unit |
Substituting a generic is the pharmacist's decision; for medicines listed in schedules A, B and C it still requires a prescription. Public sale prices published by the Directorate of Medicines and Pharmacy, recorded on 9/8/2026.
About Cardix 25 mg
Cardix 25 mg belongs to the beta blocking agents therapeutic class. In Morocco, this drug is marketed by PHI and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Cardix 25 mg, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Cardix 25 mg
Answers to common questions from Moroccan patients about this drug.